JP2015533491A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533491A5
JP2015533491A5 JP2015532125A JP2015532125A JP2015533491A5 JP 2015533491 A5 JP2015533491 A5 JP 2015533491A5 JP 2015532125 A JP2015532125 A JP 2015532125A JP 2015532125 A JP2015532125 A JP 2015532125A JP 2015533491 A5 JP2015533491 A5 JP 2015533491A5
Authority
JP
Japan
Prior art keywords
salmonella typhi
shigella
antigen
ty21a
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015532125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533491A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/059980 external-priority patent/WO2014043637A1/en
Publication of JP2015533491A publication Critical patent/JP2015533491A/ja
Publication of JP2015533491A5 publication Critical patent/JP2015533491A5/ja
Pending legal-status Critical Current

Links

JP2015532125A 2012-09-17 2013-09-16 染色体組換え操作に基づく多機能性経口ワクチン Pending JP2015533491A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261701939P 2012-09-17 2012-09-17
US61/701,939 2012-09-17
PCT/US2013/059980 WO2014043637A1 (en) 2012-09-17 2013-09-16 Multifunctional oral vaccine based on chromosome recombineering

Publications (2)

Publication Number Publication Date
JP2015533491A JP2015533491A (ja) 2015-11-26
JP2015533491A5 true JP2015533491A5 (enExample) 2016-09-01

Family

ID=50278754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015532125A Pending JP2015533491A (ja) 2012-09-17 2013-09-16 染色体組換え操作に基づく多機能性経口ワクチン

Country Status (9)

Country Link
US (1) US9750793B2 (enExample)
EP (1) EP2895596A4 (enExample)
JP (1) JP2015533491A (enExample)
KR (1) KR20150058435A (enExample)
CN (1) CN104812890A (enExample)
HK (1) HK1211980A1 (enExample)
IL (1) IL237339B (enExample)
IN (1) IN2015KN00516A (enExample)
WO (1) WO2014043637A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2910213A1 (en) * 2013-04-25 2014-10-30 Vaximm Ag Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene wt1
SG11201604911VA (en) 2013-12-18 2016-07-28 Vaximm Gmbh Novel msln targeting dna vaccine for cancer immunotherapy
CN105734001B (zh) * 2014-12-08 2020-04-07 中国人民解放军军事医学科学院生物工程研究所 一种o抗原糖链延长的甲型副伤寒沙门氏菌及其应用
WO2017007852A1 (en) * 2015-07-06 2017-01-12 Protein Potential, Llc Live attenuated oral vaccine against shigellosis and typhoid fever
GB201519734D0 (en) * 2015-11-09 2015-12-23 Univ Swansea Cancer therapy
CN106801029B (zh) * 2017-01-22 2020-05-01 山东大学 一株重组大肠杆菌及其在制备抗志贺氏菌的糖疫苗中的应用
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof
WO2020163655A1 (en) 2019-02-06 2020-08-13 Fred Hutchinson Cancer Research Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541043B2 (en) 2002-01-16 2009-06-02 The United States Of America As Represented By The Department Of Health And Human Services Vaccine for protection against Shigella sonnei disease
EP1756149B1 (en) 2004-05-24 2013-09-04 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Live, oral vaccine for protection against shigella dysenteriae serotype 1

Similar Documents

Publication Publication Date Title
JP2015533491A5 (enExample)
WO2008039408A3 (en) Live bacterial vaccines for viral infection prophylaxis or treatment
WO2019002207A1 (en) VECTORS & METHODS
CN111182920B (zh) 针对抗原的保护性免疫的诱导
WO2011025310A3 (ko) 돼지의 병원성 대장균의 부착인자가 형질전환된 약독화 살모넬라균 변이주 및 이를 포함하는 돼지의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물
CN110520153B (zh) 在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗
Yan et al. Asd-based balanced-lethal system in attenuated Edwardsiella tarda to express a heterologous antigen for a multivalent bacterial vaccine
CN104560851A (zh) 杀鲑气单胞菌活疫苗制剂和冻干疫苗制品的制备方法及应用
CN104560853B (zh) 一株鸭疫里默氏杆菌ch1减毒菌株及其构建方法和应用
CN112063551A (zh) 杀香鱼假单胞菌六型分泌系统缺失突变株及其应用
Thurlow et al. The gfc operon is involved in the formation of the O antigen capsule in Aeromonas hydrophila and contributes to virulence in channel catfish
McLaughlin et al. A mutant in the Listeria monocytogenes Fur-regulated virulence locus (frvA) induces cellular immunity and confers protection against listeriosis in mice
CN107723269B (zh) 重组鼠伤寒沙门菌二价疫苗株的构建方法及所得株和应用
Choi et al. Generation of two auxotrophic genes knock-out Edwardsiella tarda and assessment of its potential as a combined vaccine in olive flounder (Paralichthys olivaceus)
Sreerohini et al. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157: H7 and Shigella dysenteriae
Oyston et al. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection
JP5257939B2 (ja) 豚丹毒・豚マイコプラズマ肺炎経口投与型多価ワクチン
Choe et al. Characterization of Edwardsiella piscicida CK108 flagellin genes and evaluation of their potential as vaccine targets in the zebrafish model
CN101632836B (zh) 一种迟缓爱德华氏菌dna疫苗及其构建和应用
KR100765357B1 (ko) 고스트 비브리오 앵귈라룸 및 이를 함유하는 비브리오증의예방용 백신
JP2017525726A5 (enExample)
WO2012142684A1 (pt) Processo de construção de linhagem atenuada mutante de uma bactéria patogênica, vacina, vetor vacinal e uso da referida vacina.
Choi et al. Generation of killed but metabolically active (KBMA) Edwardsiella tarda and evaluation of its potential as a protective vaccine
CN102240404B (zh) 一种哈氏弧菌dna疫苗及其构建方法和应用
WO2013185337A1 (zh) 迟钝爱德华氏菌突变株及其应用